Our data support the idea that the transcriptional regulation of SnoN could be considered as a negative regulator of the TGF-β signaling pathway in DN as there appears to be a decreased expression of SnoN in STZ-induced renal tissue, with a concomitant increase in TGF-β expression. The gene discussed is TGFB1; the disease is liver dysplastic nodule.